These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 31356826)

  • 1. Long-Term Outcomes of Patients With Low Grade Cystic Renal Epithelial Neoplasms.
    Westerman ME; Cheville JC; Lohse CM; Sharma V; Boorjian SA; Leibovich BC; Thompson RH
    Urology; 2019 Nov; 133():145-150. PubMed ID: 31356826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal Neoplasms With Overlapping Features of Clear Cell Renal Cell Carcinoma and Clear Cell Papillary Renal Cell Carcinoma: A Clinicopathologic Study of 37 Cases From a Single Institution.
    Dhakal HP; McKenney JK; Khor LY; Reynolds JP; Magi-Galluzzi C; Przybycin CG
    Am J Surg Pathol; 2016 Feb; 40(2):141-54. PubMed ID: 26752401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous radiofrequency ablation for renal cell carcinoma vs. partial nephrectomy: Comparison of long-term oncologic outcomes in both clear cell and non-clear cell of the most common subtype.
    Liu N; Huang D; Cheng X; Chong Y; Wang W; Gan W; Guo H
    Urol Oncol; 2017 Aug; 35(8):530.e1-530.e6. PubMed ID: 28408296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histologic subtype needs to be considered after partial nephrectomy in patients with pathologic T1a renal cell carcinoma: papillary vs. clear cell renal cell carcinoma.
    Yoo S; You D; Jeong IG; Song C; Hong B; Hong JH; Ahn H; Kim CS
    J Cancer Res Clin Oncol; 2017 Sep; 143(9):1845-1851. PubMed ID: 28451753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do Clear Cell Papillary Renal Cell Carcinomas Have Malignant Potential?
    Diolombi ML; Cheng L; Argani P; Epstein JI
    Am J Surg Pathol; 2015 Dec; 39(12):1621-34. PubMed ID: 26426379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of Clear Cell Papillary Renal Cell Carcinoma in Low-Grade Renal Cell Carcinoma Cases: A 12-Year Retrospective Clinicopathologic Study From a Single Cancer Center.
    Gill S; Kauffman EC; Kandel S; George S; Schwaab T; Xu B
    Int J Surg Pathol; 2016 May; 24(3):207-12. PubMed ID: 26510859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting Oncologic Outcomes in Renal Cell Carcinoma After Surgery.
    Leibovich BC; Lohse CM; Cheville JC; Zaid HB; Boorjian SA; Frank I; Thompson RH; Parker WP
    Eur Urol; 2018 May; 73(5):772-780. PubMed ID: 29398265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Architectural Patterns are a Relevant Morphologic Grading System for Clear Cell Renal Cell Carcinoma Prognosis Assessment: Comparisons With WHO/ISUP Grade and Integrated Staging Systems.
    Verine J; Colin D; Nheb M; Prapotnich D; Ploussard G; Cathelineau X; Desgrandchamps F; Mongiat-Artus P; Feugeas JP
    Am J Surg Pathol; 2018 Apr; 42(4):423-441. PubMed ID: 29356723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of histology on clinicopathologic outcomes for patients with renal cell carcinoma and venous tumor thrombus: a matched cohort analysis.
    Kaushik D; Linder BJ; Thompson RH; Eisenberg MS; Lohse CM; Cheville JC; Leibovich BC; Boorjian SA
    Urology; 2013 Jul; 82(1):136-41. PubMed ID: 23642851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytomorphologic analysis of clear cell papillary renal cell carcinoma: Distinguishing diagnostic features.
    Griffin BB; Lin X
    Cancer Cytopathol; 2021 Mar; 129(3):192-203. PubMed ID: 33036062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on selected renal cell tumors with clear cell features. With emphasis on multilocular cystic clear cell renal cell carcinoma.
    Montironi R; Mazzucchelli R; Scarpelli M; Lopez-Beltran A; Cheng L
    Histol Histopathol; 2013 Dec; 28(12):1555-66. PubMed ID: 23893851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Oncologic Outcomes of Off-Clamp Robotic Partial Nephrectomy for Cystic Renal Tumors: A Propensity Score Matched-Pair Comparison of Cystic versus Pure Clear Cell Carcinoma.
    Ferriero M; Ragusa A; Mastroianni R; Tuderti G; Costantini M; Anceschi U; Misuraca L; Brassetti A; Guaglianone S; Bove AM; Leonardo C; Gallucci M; Papalia R; Simone G
    Curr Oncol; 2024 May; 31(6):2985-2993. PubMed ID: 38920711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous Cryoablation of Solitary, Sporadic Renal Cell Carcinoma: Outcome Analysis Based on Clear-Cell versus Papillary Subtypes.
    Haddad MM; Schmit GD; Kurup AN; Schmitz JJ; Boorjian SA; Geske J; Thompson RH; Callstrom MR; Atwell TD
    J Vasc Interv Radiol; 2018 Aug; 29(8):1122-1126. PubMed ID: 29887184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three-dimensional tumour volume and cancer-specific survival for patients undergoing nephrectomy to treat pT1 clear-cell renal cell carcinoma.
    Jorns J; Thiel DD; Lohse CM; Williams A; Arnold ML; Cheville JC; Leibovich BC; Parker AS
    BJU Int; 2012 Oct; 110(7):956-60. PubMed ID: 22300498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Five-year Oncologic Outcomes After Transperitoneal Robotic Partial Nephrectomy for Renal Cell Carcinoma.
    Andrade HS; Zargar H; Caputo PA; Akca O; Kara O; Ramirez D; Haber GP; Stein RJ; Kaouk JH
    Eur Urol; 2016 Jun; 69(6):1149-54. PubMed ID: 26719014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncological outcomes of minimally invasive partial versus minimally invasive radical nephrectomy for cT1-2/N0/M0 clear cell renal cell carcinoma: a propensity score-matched analysis.
    Simone G; Tuderti G; Anceschi U; Papalia R; Ferriero M; Misuraca L; Minisola F; Mastroianni R; Costantini M; Guaglianone S; Sentinelli S; Gallucci M
    World J Urol; 2017 May; 35(5):789-794. PubMed ID: 27578234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histological subtype of renal cell carcinoma significantly affects survival in the era of partial nephrectomy.
    Nguyen DP; Vertosick EA; Corradi RB; Vilaseca A; Benfante NE; Touijer KA; Sjoberg DD; Russo P
    Urol Oncol; 2016 Jun; 34(6):259.e1-8. PubMed ID: 26947350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of extensive necrosis in renal cell carcinoma.
    Collins J; Epstein JI
    Hum Pathol; 2017 Aug; 66():108-114. PubMed ID: 28669641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term oncological outcomes of cystic renal cell carcinoma according to the Bosniak classification.
    Boissier R; Ouzaid I; Nouhaud FX; Khene Z; Dariane C; Chkir S; Chelly S; Giwerc A; Allenet C; Lefrancq JB; Gimel P; Bodin T; Rioux-Leclercq N; Correas JM; Albiges L; Hetet JF; Bigot P; Bernhard JC; Long JA; Mejean A; Bensalah K;
    Int Urol Nephrol; 2019 Jun; 51(6):951-958. PubMed ID: 30977021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predominantly cystic clear cell renal cell carcinoma and multilocular cystic renal neoplasm of low malignant potential form a low-grade spectrum.
    Tretiakova M; Mehta V; Kocherginsky M; Minor A; Shen SS; Sirintrapun SJ; Yao JL; Alvarado-Cabrero I; Antic T; Eggener SE; Picken MM; Paner GP
    Virchows Arch; 2018 Jul; 473(1):85-93. PubMed ID: 29770853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.